Manipulating hepatocellular carcinoma cell fate in orthogonally cross-linked hydrogels

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6898-6906

  Lin, Tsai Yu ^a   Ki, Chang Seok ^a   Lin, Chien Chi ^a  

^a Indiana University Purdue University Indianapolis   (United States)

Author keywords

Hepatocytes; Liver tissue engineering; Microenvironment; Thiol ene hydrogels

Indexed keywords

ADDITIVES; AMINO ACIDS; CHEMICAL MODIFICATION; CROSSLINKING; HYDROGELS; PEPTIDES; POLYETHYLENE GLYCOLS; RESTORATION; TISSUE; TISSUE CULTURE; TISSUE ENGINEERING; UREA; VIRUSES;

CELL MATRIX INTERACTIONS; HEPATITIS B VIRUS INFECTION; HEPATOCELLULAR CARCINOMA CELL; HEPATOCYTES; LIVER TISSUE ENGINEERING; MATRIX METALLOPROTEINASES; MICROENVIRONMENTS; THIOL-ENES;

CELLS;

CYTOCHROME P450 3A4; DITHIOTHREITOL; MACROGOL; METALLOPROTEINASE; POLY(ETHYLENE GLYCOL)TETRA NORBORNENE; SODIUM BILE ACID COTRANSPORTER; UNCLASSIFIED DRUG; COTRANSPORTER; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; FIBRONECTIN; HYDROGEL; MACROGOL DERIVATIVE; MATRIX METALLOPROTEINASE; MESSENGER RNA; NORBORNANE DERIVATIVE; ORGANIC ANION TRANSPORTER; POLY(ETHYLENE GLYCOL)-TETRA-NORBORNENE; SODIUM-BILE ACID COTRANSPORTER; UREA;

ARTICLE; CARCINOMA CELL; CELL DENSITY; CELL ENCAPSULATION; CELL FATE; CELL INTERACTION; CELL POLARITY; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVITY; GENE EXPRESSION; HEPATITIS B; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; CELL DEDIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; CLICK CHEMISTRY; DRUG EFFECTS; GENETICS; IMMOBILIZED CELL; LIVER CELL; LIVER TUMOR; METABOLISM; TISSUE CULTURE TECHNIQUE; TUMOR CELL LINE;

HEPATITIS B VIRUS; TETRA;

CARCINOMA, HEPATOCELLULAR; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, IMMOBILIZED; CLICK CHEMISTRY; CYTOCHROME P-450 CYP3A; DITHIOTHREITOL; FIBRONECTINS; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYDROGELS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; NORBORNANES; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; POLYETHYLENE GLYCOLS; RNA, MESSENGER; SYMPORTERS; TISSUE CULTURE TECHNIQUES; UP-REGULATION; UREA;

EID: 84902080957     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.118     Document Type: Article

References (69)

1. Hewitt N.J., Lechon M.J., Houston J.B., Hallifax D., Brown H.S., Maurel P., et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 2007, 39:159-234.
2. Gomez-Lechon M.J., Castell J.V., Donato M.T. An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 2008, 4:837-854.
3. Guguen-Guillouzo C., Guillouzo A. General review on invitro hepatocyte models and their applications. Methods Mol Biol 2010, 640:1-40.
4. LeCluyse E.L., Witek R.P., Andersen M.E., Powers M.J. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 2012, 42:501-548.
5. Guillouzo A., Morel F., Fardel O., Meunier B. Use of human hepatocyte cultures for drug metabolism studies. Toxicology 1993, 82:209-219.
6. Aden D.P., Fogel A., Plotkin S., Damjanov I., Knowles B.B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979, 282:615-616.
7. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982, 42:3858-3863.
8. Itle L.J., Koh W.G., Pishko M.V. Hepatocyte viability and protein expression within hydrogel microstructures. Biotechnol Prog 2005, 21:926-932.
9. Itle L.J., Pishko M.V. Multiphenotypic whole-cell sensor for viability screening. Anal Chem 2005, 77:7887-7893.
10. Underhill G.H., Chen A.A., Albrecht D.R., Bhatia S.N. Assessment of hepatocellular function within PEG hydrogels. Biomaterials 2007, 28:256-270.
11. Li C.Y., Stevens K.R., Schwartz R.E., Alejandro B.S., Huang J.H., Bhatia S.N. Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng Part A 2014, Available from:. http://www.ncbi.nlm.nih.gov/pubmed/24498910, 10.1089/ten.TEA.2013.0667.
12. Liu Tsang V., Chen A.A., Cho L.M., Jadin K.D., Sah R.L., DeLong S., et al. Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J 2007, 21:790-801.
13. Chen A.A., Underhill G.H., Bhatia S.N. Multiplexed, high-throughput analysis of 3D microtissue suspensions. Integr Biol 2010, 2:517-527.
14. Cho N.J., Elazar M., Xiong A., Lee W., Chiao E., Baker J., et al. Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel. Biomed Mater 2009, 4:011001.
15. Vanderhooft J.L., Mann B.K., Prestwich G.D. Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules 2007, 8:2883-2889.
16. Kim M., Lee J.Y., Jones C.N., Revzin A., Tae G. Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes. Biomaterials 2010, 31:3596-3603.
17. You J., Shin D.S., Patel D., Gao Y., Revzin A. Multilayered heparin hydrogel microwells for cultivation of primary hepatocytes. Adv Healthc Mater 2014, 3:126-132.
18. Wu Y., Zhao Z., Guan Y., Zhang Y. Galactosylated reversible hydrogels as scaffold for HepG2 spheroid generation. Acta Biomater 2014, 10:1965-1974.
19. van Zijl F., Mikulits W. Hepatospheres: three dimensional cell cultures resemble physiological conditions of the liver. World J Hepatol 2010, 2:1-7.
20. Li Y.S., Harn H.J., Hsieh D.K., Wen T.C., Subeq Y.M., Sun L.Y., et al. Cells and materials for liver tissue engineering. Cell Transplant 2013, 22:685-700.
21. Page H., Flood P., Reynaud E.G. Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res 2013, 352:123-131.
22. Palakkan A.A., Hay D.C., Anil Kumar P.R., Kumary T.V., Ross J.A. Liver tissue engineering and cell sources: issues and challenges. Liver Int 2013, 33:666-676.
23. DeForest C.A., Anseth K.S. Cytocompatible click-based hydrogels with dynamically tunable properties through orthogonal photoconjugation and photocleavage reactions. Nat Chem 2011, 3:925-931.
24. Lin C.C., Raza A., Shih H. PEG hydrogels formed by thiol-ene photo-click chemistry and their effect on the formation and recovery of insulin-secreting cell spheroids. Biomaterials 2011, 32:9685-9695.
25. McCall J.D., Anseth K.S. Thiol-ene photopolymerizations provide a facile method to encapsulate proteins and maintain their bioactivity. Biomacromolecules 2012, 13:2410-2417.
26. Benton J.A., Fairbanks B.D., Anseth K.S. Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials 2009, 30:6593-6603.
27. Shih H., Lin C.C. Visible-light-mediated thiol-ene hydrogelation using eosin-Y as the only photoinitiator. Macromol Rapid Commun 2013, 34:269-273.
28. Raza A., Lin C.C. The influence of matrix degradation and functionality on cell survival and morphogenesis in PEG-based hydrogels. Macromol Biosci 2013, 13:1048-1058.
29. Hao Y., Shih H., Munoz Z., Kemp A., Lin C.C. Visible light cured thiol-vinyl hydrogels with tunable degradation for 3D cell culture. Acta Biomater 2014, 10:104-114.
30. Anderson S.B., Lin C.C., Kuntzler D.V., Anseth K.S. The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels. Biomaterials 2011, 32:3564-3574.
31. Shih H., Lin C.C. Cross-linking and degradation of step-growth hydrogels formed by thiol-ene photoclick chemistry. Biomacromolecules 2012, 13:2003-2012.
32. Raza A., Ki C.S., Lin C.C. The influence of matrix properties on growth and morphogenesis of human pancreatic ductal epithelial cells in 3D. Biomaterials 2013, 34:5117-5127.
33. Ki C.S., Shih H., Lin C.C. Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells. Biomacromolecules 2013, 14:3017-3026.
34. Fairbanks B.D., Schwartz M.P., Bowman C.N., Anseth K.S. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009, 30:6702-6707.
35. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
37. Sivertsson L., Ek M., Darnell M., Edebert I., Ingelman-Sundberg M., Neve E.P. CYP3A4 catalytic activity is induced in confluent Huh7 hepatoma cells. Drug Metab Dispos 2010, 38:995-1002.
38. Sivertsson L., Edebert I., Palmertz M.P., Ingelman-Sundberg M., Neve E.P. Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation. Mol Pharmacol 2013, 83:659-670.
39. Olsavsky K.M., Page J.L., Johnson M.C., Zarbl H., Strom S.C., Omiecinski C.J. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol 2007, 222:42-56.
40. Sumida K., Igarashi Y., Toritsuka N., Matsushita T., Abe-Tomizawa K., Aoki M., et al. Effects of DMSO on gene expression in human and rat hepatocytes. Hum Exp Toxicol 2011, 30:1701-1709.
41. Hoekstra R., Nibourg G.A., van der Hoeven T.V., Ackermans M.T., Hakvoort T.B., van Gulik T.M., et al. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 2011, 43:1483-1489.
42. Treyer A., Musch A. Hepatocyte polarity. Compr Physiol 2013, 3:243-287.
43. Sainz B., TenCate V., Uprichard S.L. Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J 2009, 6:103.
44. Ploss A., Khetani S.R., Jones C.T., Syder A.J., Trehan K., Gaysinskaya V.A., et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 2010, 107:3141-3145.
45. Molina-Jimenez F., Benedicto I., Dao Thi V.L., Gondar V., Lavillette D., Marin J.J., et al. Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology 2012, 425:31-39.
46. Tran N.M., Dufresne M., Duverlie G., Castelain S., Defarge C., Paullier P., et al. An appropriate selection of a 3D alginate culture model for hepatic Huh-7 cell line encapsulation intended for viral studies. Tissue Eng Part A 2013, 19:103-113.
47. March S., Ng S., Velmurugan S., Galstian A., Shan J., Logan D.J., et al. Amicroscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 2013, 14:104-115.
48. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012, 1:e00049.
49. Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981, 2:1129-1133.
50. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. JClin Virol 2005, 34(Suppl.1):S1-S3.
51. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
52. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991, 40:1-25.
53. Wasley A., Kruszon-Moran D., Kuhnert W., Simard E.P., Finelli L., McQuillan G., et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. JInfect Dis 2010, 202:192-201.
54. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002, 99:15655-15660.
55. Hantz O., Parent R., Durantel D., Gripon P., Guguen-Guillouzo C., Zoulim F. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. JGen Virol 2009, 90:127-135.
56. Schulze A., Mills K., Weiss T.S., Urban S. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 2012, 55:373-383.
57. Ni Y., Lempp F.A., Mehrle S., Nkongolo S., Kaufman C., Falth M., et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2014, 146:1070-1083.
58. Iwamoto M., Watashi K., Tsukuda S., Aly H.H., Fukasawa M., Fujimoto A., et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun 2014, 443:808-813.
59. Li D., Han Y., Meng X., Sun X., Yu Q., Li Y., et al. Effect of regular organic solvents on cytochrome P450-mediated metabolic activities in rat liver microsomes. Drug Metab Dispos 2010, 38:1922-1925.
60. Nishimura M., Ueda N., Naito S. Effects of dimethyl sulfoxide on the gene induction of cytochrome P450 isoforms, UGT-dependent glucuronosyl transferase isoforms, and ABCB1 in primary culture of human hepatocytes. Biol Pharm Bull 2003, 26:1052-1056.
61. Bhat P., Snooks M.J., Anderson D.A. Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms. JVirol 2011, 85:12474-12481.
62. Kosters A., Karpen S.J. Bile acid transporters in health and disease. Xenobiotica 2008, 38:1043-1071.
63. Roma M.G., Crocenzi F.A., Mottino A.D. Dynamic localization of hepatocellular transporters in health and disease. World J Gastroenterol 2008, 14:6786-6801.
64. Ling H., Sylvestre J.R., Jolicoeur P. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 2010, 29:4543-4554.
65. Sa-ngiamsuntorn K., Wongkajornsilp A., Kasetsinsombat K., Duangsa-ard S., Nuntakarn L., Borwornpinyo S., et al. Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers. BMC Biotechnol 2011, 11:89.
66. Pan Y.Z., Gao W., Yu A.M. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 2009, 37:2112-2117.
67. Court M.H., Zhang X., Ding X., Yee K.K., Hesse L.M., Finel M. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 2012, 42:266-277.
68. Dietrich C.G., Martin I.V., Porn A.C., Voigt S., Gartung C., Trautwein C., et al. Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4alpha and PGC1alpha. Am J Physiol Gastrointest Liver Physiol 2007, 293:G585-G590.
69. Le Vee M., Jigorel E., Glaise D., Gripon P., Guguen-Guillouzo C., Fardel O. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur J Pharm Sci 2006, 28:109-117.